Stocks and Investing Stocks and Investing
Wed, July 5, 2023
Mon, July 3, 2023
Fri, June 30, 2023
Thu, June 29, 2023

Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $6 on, Jun 29th, 2023


Published on 2024-10-28 04:34:38 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $6 on, Jun 29th, 2023.

Gil has made no other calls on TSHA in the last 4 months.



There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 1 agrees with Gil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Lapides of "Morgan Stanley" Maintained at Hold with Decreased Target to $1 on, Thursday, March 30th, 2023


These are the ratings of the 4 analyists that currently disagree with Gil


  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $2 on, Monday, May 15th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $2 on, Thursday, March 30th, 2023
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Thursday, March 30th, 2023
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $5 on, Thursday, March 30th, 2023